MOSCOW (Reuters) – Russia’s sovereign wealth fund said on Wednesday it will supply India’s Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in India.
The Russian Direct Investment Fund (RDIF) added that it had agreed to cooperate on clinical trials and the distribution of the vaccine with the Indian firm.
(Reporting by Polina Ivanova and Maria Kiselyova; Writing by Gabrielle Tétrault-Farber; Editing by Kevin Liffey)
Watch the NFL Draft with amNY
NFL to open academy in Australia to identify and develop young prospects
Anze Kopitar scores in overtime, Kings beat Oilers 5-4 in Game 2 to tie series
Defending champion Golden Knights beat Stars 3-1 to take 2-0 series lead home to Vegas
Shai Gilgeous-Alexander’s 33 points lead Thunder past Pelicans 124-92 as OKC takes a 2-0 lead
Heartless perp in Midtown grabs senior’s walker in assault: cops
Controversy over spiked antifascist speech dominates Italy’s Liberation Day anniversary
Tough new EPA rules would force coal-fired power plants to capture emissions or shut downWatch the NFL Draft with amNY
Ship comes under attack off coast of Yemen as Houthi rebel campaign appears to gain new speed
